论文部分内容阅读
目的:分析慢性阻塞性肺疾病合并呼吸衰竭患者临床效果。方法:抽选2012年4月-2014年5月,我院接收慢性阻塞性肺疾病合并呼吸衰竭患者60例,按入院编号分成两组(实验组、对照组),实验组患者给予无创正压通气治疗,对照组患者给予临床基础治疗,比对两组患者治疗效果。结果:实验组患者治疗好转率(96.7%)、不良反应总率(3.3%)和对照组相比,差异性明显(P<0.05)。结论:临床治疗慢性阻塞性肺疾病合并呼吸衰竭患者期间给予无创正压通气治疗,安全、有效,可控制患者病情发展,改善生活现状,值得使用。
Objective: To analyze the clinical effect of chronic obstructive pulmonary disease (COPD) patients with respiratory failure. Methods: From April 2012 to May 2014, 60 patients with chronic obstructive pulmonary disease and respiratory failure in our hospital were divided into two groups (experimental group and control group) according to admission number. Patients in experimental group were given noninvasive positive pressure Ventilation treatment, the control group of patients given clinical basic treatment, compared with two groups of patients with treatment. Results: The improvement rate (96.7%) and adverse reaction rate (3.3%) in the experimental group were significantly different from those in the control group (P <0.05). Conclusion: Noninvasive positive pressure ventilation is given during the treatment of chronic obstructive pulmonary disease (COPD) patients with respiratory failure. It is safe, effective and can control the patient’s condition and improve the life status. It is worth using.